查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856713

玻璃體視網膜手術器械市場（按器械類型、應用、最終用戶和技術分類）－2025-2032年全球預測

Vitreoretinal Surgery Devices Market by Device Type, Application, End User, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，玻璃體視網膜手術器械市場規模將達到 39.3 億美元，複合年成長率為 6.16%。

關鍵市場統計數據
基準年 2024 24.3億美元
預計年份：2025年 25.8億美元
預測年份 2032 39.3億美元
複合年成長率 (%) 6.16%

對塑造現代玻璃體視網膜手術實踐的臨床、技術、監管和商業性力量進行權威性指導

玻璃體視網膜手術已進入一個以技術快速進步、手術流程標準化和日益關注患者療效為特徵的階段。本概要概述了影響玻璃體視網膜手術臨床和器械發展的關鍵因素，為深入探討不斷變化的動態、監管壓力以及硬體、軟體和耗材之間不斷演變的相互作用提供了背景。其目的是為決策者——臨床醫生、醫院採購負責人、器械製造商和投資者——提供這些發展的實際意義，並重點闡述融合的技術創新如何改變手術室工作流程和術後護理路徑。

臨床醫生日益需要能夠減少術中變異性並提供可重複性能的器械，製造商也積極響應，推出模組化系統，強調人體工學、數位化整合和一次性耗材組件，以提高無菌性並縮短手術時間。同時，手術團隊正在採用多模態成像和更快的切割機制來應對牽引性視網膜剝離和增生性玻璃體視網膜疾病等複雜病理。監管機構對器械可追溯性、無菌驗證和軟體安全性的審查力度也在不斷加大，迫使製造商從研發初期就加強其文件和監管策略。這些因素共同加速了產品改進的迭代週期，而臨床回饋和真實世界證據在產品商業化和推廣應用的過程中發揮著至關重要的作用。

從臨床促進因素到市場促進因素再到營運考量，採購相關人員正在努力平衡設備採購與耗材捆綁銷售和軟體訂閱模式的興起，這些模式正在改變醫療服務的經濟模式。因此，融合直接臨床教育、結果資料傳播和靈活商業性結構的市場策略正日益普及。綜上所述，本導言透過強調臨床需求、技術創新、監管關注和商業性演變之間的相互關係，為後續分析奠定了基礎，這些關係共同定義了玻璃體視網膜手術器械的現狀。

技術融合、結果主導應用和供應鏈韌性如何從根本上重新定義玻璃體視網膜手術解決方案的未來

由於技術的快速成熟、手術複雜性的增加以及對基於價值的治療結果的日益重視，玻璃體視網膜治療領域正經歷著變革性的轉變。手術器械和視覺化技術的創新，以及圍手術全期影像技術的進步，使外科醫師能夠進行更精準的操作，同時減少意外的組織損傷。這種融合正在改變病例選擇和治療流程，使得曾經技術難度極高的手術現在能夠更穩定地完成，並且手術時間更短。同時，用於手術規劃和術中導航的數位化平台正開始實現各中心手術流程的標準化，從而提高基準，並使不同外科醫生之間的療效比較更加可靠。

同時，微創手術和微切口玻璃體切除術系統的發展趨勢正在重塑技術格局，並推動了更纖細器械的研發。這些技術進步也影響著耗材、套管系統和填充策略，迫使器材製造商在更廣泛的產品線中進行創新，而非僅依賴單一產品的優勢。此外， 3D成像和增強視覺化系統的出現正在改變外科醫生與手術區域的交互方式，促使人體工學不斷改進，並將成像技術與切割平台整合。這些發展也促進了遠端教育和指導，使技術水平有限的地區也能獲得先進技術。

同時，非技術因素也在推動結構性變革。支付者和醫療保健系統日益重視基於結果的證據，臨床註冊、真實世界證據和病患報告結局指標的重要性也隨之提升。因此，製造商目前優先考慮縱向資料收集，並與領先的臨床中心合作，以檢驗其設備的價值提案。供應鏈韌性和成本控制仍然是核心關注點，製造商正在採用精實生產、在地採購策略，並實現供應商多元化，以降低中斷風險。總而言之，這些變革性轉變正在重塑競爭動態，並加速整合系統的普及應用。這些整合系統結合了切割機械、先進影像處理和耗材生態系統，旨在提供全面的手術解決方案。

評估關稅上漲如何推動設備生命週期內的供應鏈重組、採購創新和監管調整。

近期關稅政策的訂定，增加了醫療設備製造商和醫療保健系統供應鏈及籌資策略的複雜性。關稅政策促使企業更加重視製造地的選擇，並重新評估零件採購和最終組裝地點。許多公司已啟動近岸外包和回流生產計劃，以降低跨境關稅的影響並縮短前置作業時間；而另一些公司則透過供應商多元化來維持冗餘。這些調整往往需要在單位成本、營運彈性以及當地監管機構的器械核准合規時間之間做出權衡。

醫院和門診手術中心正在重新評估資本設備及相關耗材的總擁有成本，以應對關稅帶來的衝擊。採購團隊正在協商更長期的供應協議，並探索寄售或庫存管理模式，以平抑關稅主導的投入成本波動所帶來的價格波動。同時，製造商正在考慮其他商業模式，例如捆綁定價和訂閱服務，這些模式可以鎖定多年合作關係，並在一定程度上降低製造商因關稅意外波動而面臨的風險。對於依賴複雜全球供應鏈取得精密零件和電子子系統的公司而言，關稅正在提升跨境供應商夥伴關係以及合約保護措施在應對關稅突發波動方面的戰略價值。

供應鏈重組也引入了監管和海關方面的考量，需要提交額外的監管文件和補充檢驗，以確保持續符合安全和無菌標準。因此，監管事務團隊擴大參與採購決策。在臨床領域，外科醫師和醫院管理者都意識到器械供應可能中斷，以及耗材供應商中途變更對其營運的影響。因此，制定應急計劃並在臨床、採購和供應商團隊之間保持清晰的溝通，對於在關稅壓力下維持醫療服務的連續性和手術量至關重要。

整合設備、應用、終端用戶和技術細分洞察，揭示臨床需求與工程和商業機會的交匯點

細緻的細分框架揭示了產品設計、臨床應用案例、終端用戶環境和實行技術如何相互作用，從而塑造創新重點和推廣路徑。基於設備類型的競爭格局包括內雷射光凝探針、照明系統、眼內填充物、套管針系統和玻璃體切除系統。玻璃體切除平台還根據規格選項進一步細分，包括 20G、23G、25G 和 27G，以滿足不同的手術入路和液體控制需求。這些器械差異導致不同的臨床工作流程，規格和相關器械的選擇直接影響切口大小、傷口完整性和術後恢復。因此，製造商正在優先考慮其設備組合的模組化和互通性，以滿足不同的手術偏好。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合27G和29G高速設備，以提高手術效率和病患復原速度
  • 採用術中光同調斷層掃瞄增強玻璃體視網膜手術中的即時視覺化
  • 市場對微創玻璃體手術器械的需求日益成長，這類器械能夠實現更小的切口和更短的手術時間。
  • 開發具有自動眼內壓控制功能的智慧注射系統，以實現更安全的視網膜手術
  • 藥物塗層微型套管可實現視網膜治療中藥物傳輸和玻璃體切除的同步進行。
  • 利用擴增實境輔助手術導引提高複雜黃斑裂孔和視網膜剝離修復的精準度
  • 擴展用於玻璃體視網膜手術的機器人輔助平台，以減少手術過程中的震顫並實現精細的運動控制。
  • 將人工智慧主導的分析功能整合到手術主機中，以實現預測性維護和個人化手術流程最佳化
  • 醫療器材製造商和生技公司之間活性化合作，將基因療法結合到玻璃體手術中

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 玻璃體視網膜手術器械市場（依器械類型分類）

  • 內雷射光凝探針
  • 照明系統
  • 眼內填塞
  • 套管針系統
  • 玻璃體手術系統
    • 20G
    • 23G
    • 25G
    • 27G

第9章 依應用分類的玻璃體視網膜手術器械市場

  • 糖尿病視網膜病變
  • 視網膜前膜手術
  • 黃斑裂孔修復手術
  • 視網膜剝離修復

第10章 玻璃體視網膜手術器械市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專業眼科診所

第11章 玻璃體視網膜手術器械市場（依技術分類）

  • 切割機構
    • 斷頭台切割機
    • 超音波切割器
  • 影像系統
    • 常規影像
    • 3D成像

第12章 玻璃體視網膜手術器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 玻璃體視網膜手術器械市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國玻璃體視網膜手術器械市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Alcon Inc.
    • Johnson & Johnson Vision Care, Inc.
    • Bausch & Lomb Incorporated
    • Carl Zeiss Meditec AG
    • Topcon Corporation
    • NIDEK Co., Ltd.
    • DORC Ophthalmic Systems bv
    • Synergetics USA, Inc.
    • IRIDEX Corporation
    • Santen Pharmaceutical Co., Ltd.
Product Code: MRR-742BD518522B

The Vitreoretinal Surgery Devices Market is projected to grow by USD 3.93 billion at a CAGR of 6.16% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.43 billion
Estimated Year [2025] USD 2.58 billion
Forecast Year [2032] USD 3.93 billion
CAGR (%) 6.16%

An authoritative orientation to the clinical, technological, regulatory, and commercial forces reshaping contemporary vitreoretinal surgical practice

The vitreoretinal surgical landscape has entered a phase defined by rapid technological refinement, procedural standardization, and heightened attention to patient outcomes. This executive introduction outlines the critical elements shaping clinical practice and device development across vitreoretinal interventions, setting context for a deeper examination of shifting dynamics, regulatory pressures, and the evolving interplay between hardware, software, and consumables. The intent here is to orient decision-makers-clinicians, hospital procurement leaders, device manufacturers, and investors-toward the practical implications of these developments while emphasizing how converging innovations are changing both operating room workflows and post-operative care pathways.

Clinicians increasingly demand devices that deliver reproducible performance with reduced intraoperative variability, and manufacturers are responding with modular systems that emphasize ergonomics, digital integration, and single-use consumable components to enhance sterility and reduce procedure time. Simultaneously, surgical teams are adopting multimodal imaging and higher-speed cutting mechanics to address complex pathologies such as tractional retinal detachments and proliferative vitreoretinopathy. Regulatory scrutiny has intensified around device traceability, sterilization validation, and software safety, prompting manufacturers to strengthen documentation and regulatory strategy early in development. Taken together, these factors are accelerating an iterative cycle of product refinement where clinical feedback loops and real-world evidence now play a defining role in commercialization and adoption pathways.

Transitioning from clinical drivers to market and operational considerations, procurement stakeholders are balancing capital equipment procurement with the emergence of bundled consumables and software subscription models that shift the economics of care delivery. As a result, go-to-market strategies increasingly blend direct clinical education, outcomes data dissemination, and flexible commercial structures. In sum, this introduction frames the subsequent analysis by highlighting the nexus of clinical demand, technological innovation, regulatory attention, and commercial evolution that defines the current state of vitreoretinal surgery devices.

How technological convergence, outcome-driven adoption, and supply chain resilience are fundamentally redefining the future of vitreoretinal surgical solutions

The landscape of vitreoretinal care is experiencing transformative shifts driven by rapid technological maturation, increasing procedural complexity, and an expanding emphasis on value-based outcomes. Innovations in surgical instrumentation and visualization have converged with improvements in perioperative imaging, enabling surgeons to perform more precise maneuvers while reducing collateral tissue trauma. This confluence is altering case selection and treatment algorithms, as procedures that were once considered technically demanding now proceed with greater consistency and shorter operative times. In parallel, digital platforms for surgical planning and intraoperative guidance have begun to standardize techniques across institutions, elevating baseline performance and enabling more reliable inter-surgeon comparisons.

Concurrently, the technology landscape is being reshaped by the push toward minimally invasive approaches and microincisional vitrectomy systems that emphasize smaller gauge instrumentation. These technical refinements have implications for consumables, trocar systems, and tamponade strategies, and they compel device suppliers to innovate across a broader portfolio rather than rely on single-product leadership. Additionally, the emergence of three-dimensional imaging and enhanced visualization systems is changing how surgeons interact with the operative field, leading to iterative enhancements in ergonomics and integration between imaging and cutting platforms. These developments also facilitate remote education and proctoring, broadening access to advanced techniques in regions with limited specialist coverage.

At the same time, non-technical forces are prompting structural change. Payers and healthcare systems increasingly require outcome-based evidence, which has elevated the importance of clinical registries, real-world evidence, and patient-reported outcome measures. As a result, manufacturers now prioritize longitudinal data collection and collaborative studies with leading clinical centers to validate device value propositions. Supply chain resilience and cost containment remain central concerns, and manufacturers are adopting lean production, local sourcing strategies, and diversified supplier bases to mitigate disruption risk. Taken together, these transformative shifts are redefining competitive dynamics and accelerating the adoption of integrated systems that combine cutting mechanics, advanced imaging, and consumable ecosystems to deliver comprehensive procedural solutions.

Assessing how elevated tariff dynamics are prompting supply chain reconfiguration, procurement innovation, and regulatory alignment across device lifecycles

Tariff policies introduced in recent years have introduced additional complexity into supply chains and procurement strategies for medical device manufacturers and health systems. Tariffs have increased the attention paid to manufacturing footprint decisions, prompting a reassessment of where components are sourced and final assembly occurs. Many firms have initiated nearshoring or reshoring projects to reduce exposure to cross-border levies and to shorten lead times, while others have pursued supplier diversification to maintain redundancy. These adjustments often carry trade-offs between unit cost, operational flexibility, and regulatory compliance timelines for device approvals in local jurisdictions.

Hospitals and ambulatory surgical centers are responding by reevaluating total cost of ownership for capital equipment and associated consumables. Purchasing teams are negotiating longer-term supply agreements and exploring consignment or managed inventory models to smooth price volatility tied to tariff-driven input cost swings. In turn, manufacturers are considering alternative commercial constructs such as bundled pricing and subscription offerings that lock in multi-year relationships and partially de-risk manufacturers from episodic tariff fluctuations. For companies that rely on complex global supply chains for precision components and electronic subsystems, tariffs have heightened the strategic value of cross-border supplier partnerships and contractual protections against sudden tariff changes.

Regulatory and customs considerations also come into play, as reconfigured supply chains may trigger additional regulatory submissions or require supplementary validation to ensure continued compliance with safety and sterilization standards. As a result, regulatory affairs teams have become more deeply involved in sourcing and procurement decisions. In the clinical sphere, surgeons and hospital administrators are mindful of potential disruptions to device availability and the operational impact of switching consumable suppliers midstream. Consequently, contingency planning and clear communication across clinical, procurement, and supplier teams are now essential to preserve continuity of care and maintain surgical throughput despite tariff-related pressures.

Integrating device, application, end-user, and technology segmentation insights to reveal where clinical needs intersect with engineering and commercial opportunity

A nuanced segmentation framework reveals how product design, clinical use cases, end-user environments, and enabling technologies interact to shape innovation priorities and adoption pathways. Based on device type, the competitive landscape encompasses Endolaser Photocoagulation Probe, Illumination System, Intraocular Tamponade, Trocar Cannula System, and Vitrectomy System, with vitrectomy platforms further differentiated by gauge options including 20G, 23G, 25G, and 27G to meet varying balances of access and fluidics control. These device distinctions translate into differential clinical workflows, where choice of gauge and associated instruments directly influences incision size, wound integrity, and post-operative recovery dynamics. Consequently, manufacturers prioritize modularity and cross-compatibility within their device portfolios to serve diverse surgical preferences.

Based on application, clinical focus areas such as Diabetic Retinopathy, Epiretinal Membrane Surgery, Macular Hole Repair, and Retinal Detachment Repair drive distinct technical requirements and outcome measures. For instance, tractional disease seen in proliferative diabetic retinopathy demands robust fluidics and high-performance cutting mechanisms, whereas macular hole repair places premium emphasis on delicate membrane peeling and precision illumination. These varied clinical imperatives shape R&D priorities and determine where investments in advanced cutters or superior visualization technologies will yield the greatest clinical and commercial returns. Moreover, procedural nuances and surgeon training patterns influence adoption curves across applications, making clinical education and evidence generation critical to market penetration.

Based on end user, differences among Ambulatory Surgical Center, Hospital, and Specialty Eye Clinic settings shape procurement preferences, device footprint tolerance, and service expectations. Ambulatory settings often seek compact systems with rapid turnover and simplified consumables, hospitals weigh integration with broader departmental IT and sterilization workflows, and specialty eye clinics balance investment in high-end imaging with procedural volume considerations. These operational distinctions affect not only initial purchasing criteria but also long-term maintenance contracts and consumable purchasing behavior.

Based on technology, the market differentiates between Cutting Mechanism and Imaging System advances. Cutting mechanisms partition into Guillotine Cutter and Ultrasonic Cutter approaches, each presenting distinct trade-offs in vitreous removal efficiency, tissue interaction, and thermal profile. Imaging systems distinguish between Conventional Imaging and Three-Dimensional Imaging, with three-dimensional platforms increasingly enabling depth perception and collaborative viewing that enhance surgical precision and teaching. The interplay between cutting mechanics and imaging capability is central to system-level differentiation, and successful platform strategies integrate both domains to deliver coherent surgeon experiences and measurable improvements in procedural performance.

Regional adoption patterns, regulatory diversity, and healthcare infrastructure differences that determine how vitreoretinal innovations scale across global markets

Regional dynamics exert significant influence on strategic priorities, regulatory pathways, and adoption patterns across the vitreoretinal landscape. The Americas exhibit concentrated centers of clinical research and high-volume tertiary care institutions that often drive early adoption of advanced visualization and cutting platforms. Clinical trial activity and post-market surveillance initiatives in these settings shape the evidence base used by global manufacturers to refine product claims and build clinician trust. In contrast, Europe, Middle East & Africa presents a heterogeneous mix of reimbursement environments and regulatory frameworks, which compels manufacturers to pursue localized strategies, establish regional partnerships, and tailor commercial models to country-specific procurement processes. This region's diversity also creates opportunities for mid-sized specialty clinics to act as innovation hubs where iterative adoption and clinician-led optimization occur.

Asia-Pacific demonstrates rapidly evolving demand characteristics driven by demographic shifts, expanding access to specialty care, and investments in surgical infrastructure. In many parts of this region, adoption trajectories are influenced by a strong emphasis on cost-effectiveness and the need for scalable solutions that can be deployed across varying care settings. Consequently, manufacturers often prioritize adaptable platforms, tiered product offerings, and strategic collaborations with regional distributors to expand reach. Across all regions, differences in training pathways, wiring of hospital IT systems, and regulatory submission practices require manufacturers to align launch strategies with local clinical champions and reimbursement stakeholders. Taken together, these regional distinctions underscore the importance of flexible commercial models and localized evidence generation to accelerate uptake and sustain long-term engagement with health systems.

Examining the competitive landscape where legacy capabilities, specialized innovation, and digital platform strategies converge to define industry leaders

Competitive dynamics in the vitreoretinal domain are shaped by a mix of established medical device incumbents, specialized ophthalmic suppliers, imaging and software innovators, and agile start-ups focused on niche clinical challenges. Established players maintain advantages in scale, distribution networks, and clinical relationships, while specialist firms often lead in focused technical breakthroughs such as novel tamponade chemistries, refined trocar designs, or next-generation cutter tips. Imaging software providers and digital platform entrants are increasingly influential, as their capabilities for intraoperative visualization, image processing, and data analytics augment hardware value and create new revenue streams tied to software services.

Partnerships between device manufacturers and clinical centers are common and provide a pathway to collect rigorous real-world evidence and iterate product improvements based on direct surgical feedback. In parallel, supply chain partnerships and service-level agreements are becoming competitive differentiators, with after-sales support, instrument reprocessing services, and consumable logistics forming significant parts of customer value propositions. Intellectual property portfolios, regulatory experience, and the ability to secure clinical endorsements shape competitive positioning, and firms that successfully combine technical innovation with robust clinical validation tend to achieve stronger adoption. Ultimately, success hinges on delivering integrated solutions that reduce procedural complexity, demonstrate reproducible outcomes, and align with institutional procurement priorities.

Actionable strategic priorities for manufacturers and health systems to synchronize innovation, evidence, and commercial agility for durable competitive advantage

Industry leaders should pursue an integrated approach that aligns product innovation, clinical evidence generation, and flexible commercial models to capture sustainable advantage. First, prioritize system-level integration that pairs advanced cutting mechanics with enhanced imaging modalities and refined consumables to deliver measurable improvements in procedural efficiency and clinical outcomes. By designing products for modular upgrades and cross-compatibility, manufacturers can extend platform lifecycles and reduce barriers to adoption among facilities with diverse procedural volumes. Second, invest in robust clinical evidence programs that go beyond single-center studies; longitudinal registries and multicenter collaborative studies will reinforce claims around safety, efficacy, and patient-centered outcomes and will support payer conversations and hospital procurement evaluations.

Third, strengthen supply chain resilience through dual sourcing, regional manufacturing hubs, and inventory management innovations to minimize disruption risk and mitigate the operational impacts of tariff volatility. Fourth, adopt flexible commercial models, including subscription pricing, managed service arrangements, and bundled consumable agreements that align with hospital budgeting cycles and reduce capital barriers for ambulatory and specialty clinic settings. Fifth, emphasize comprehensive training and education initiatives, leveraging three-dimensional imaging and remote proctoring to shorten learning curves and accelerate safe adoption across geographies. Lastly, engage proactively with regulatory and reimbursement stakeholders to anticipate changes, streamline device approvals, and demonstrate value in context of evolving payer requirements. Collectively, these actions create a defensible market position and foster long-term partnerships with surgical centers and health systems.

A transparent, clinician-informed research approach combining primary expert interviews, clinical literature synthesis, and regulatory and patent analysis to ensure robust insights

The research underpinning this analysis combines primary qualitative engagement with clinical and industry experts, systematic review of peer-reviewed clinical literature, and examination of publicly available regulatory filings and patent activity. Primary research included structured interviews with vitreoretinal surgeons, hospital procurement leaders, and device engineers to capture first-hand perspectives on clinical unmet needs, device performance trade-offs, and operational constraints. Secondary sources encompassed clinical journals, procedural guidelines, and technical standards that inform device design and surgical best practices. These sources were triangulated to validate thematic findings and to ensure consistency with contemporary clinical practice.

Data integrity was reinforced through cross-validation of interview insights against clinical registry trends and regulatory documentation to identify consistent patterns and to mitigate potential bias from single-source perspectives. In addition, a rigorous review of clinical outcomes literature and procedural technique papers provided the evidence base for technology and application-level conclusions. Throughout the methodology, emphasis was placed on transparency of assumptions, reproducibility of analytical steps, and documentation of limitations, including potential regional variations in practice and the evolving nature of technology adoption. This approach yields a balanced synthesis of expert judgment and documented clinical evidence, suitable for informing strategic decisions in product development, market entry, and long-term portfolio planning.

Synthesis of technological, clinical, and commercial drivers that will determine which device strategies translate into sustained clinical adoption and institutional value

The cumulative analysis highlights a sector in flux, propelled by technological innovation, shifting clinical expectations, and evolving commercial imperatives. Advances in microincisional vitrectomy, enhanced illumination, and three-dimensional imaging are improving surgical precision and expanding the range of treatable pathologies, while supply chain pressures and tariff-related dynamics are reshaping manufacturing and procurement strategies. Clinicians, manufacturers, and health system leaders who align around integrated solutions, outcome-focused evidence, and resilient supply models will be best positioned to deliver improved patient care and to sustain competitive advantage.

Looking ahead, the interplay between device-level innovation and system-level commercial models will determine which technologies achieve broad clinical penetration. Success will favor organizations that can demonstrate clear benefits to operative efficiency, patient outcomes, and total cost of care, while also offering practical implementation pathways for diverse clinical settings. In this context, strategic investments in clinical partnerships, adaptable platforms, and localized support infrastructure will differentiate leaders from followers. The sector thus demands a balanced approach that pairs bold technical innovation with meticulous attention to real-world operational and regulatory realities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of high-speed 27G and 29G instrumentation to improve surgical efficiency and patient recovery
  • 5.2. Adoption of intraoperative optical coherence tomography for enhanced real-time visualization during vitreoretinal procedures
  • 5.3. Growing demand for minimally invasive vitrectomy tools with reduced incision sizes and shorter operating times
  • 5.4. Development of smart infusion systems with automated intraocular pressure control for safer retinal surgeries
  • 5.5. Emergence of drug-coated microcannulas enabling simultaneous drug delivery and vitreous removal in retinal therapies
  • 5.6. Use of augmented reality assisted surgical navigation to increase precision in complex macular hole and retinal detachment repairs
  • 5.7. Expansion of robotic-assisted vitreoretinal platforms for tremor reduction and fine motion control in delicate procedures
  • 5.8. Introduction of disposable single-use vitrectomy instruments to lower infection risk and streamline operating room workflows
  • 5.9. Integration of AI-driven analytics in surgical consoles for predictive maintenance and personalized procedure optimization
  • 5.10. Rising collaboration between device manufacturers and biotech firms for combined gene therapy delivery during vitrectomy

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vitreoretinal Surgery Devices Market, by Device Type

  • 8.1. Endolaser Photocoagulation Probe
  • 8.2. Illumination System
  • 8.3. Intraocular Tamponade
  • 8.4. Trocar Cannula System
  • 8.5. Vitrectomy System
    • 8.5.1. 20G
    • 8.5.2. 23G
    • 8.5.3. 25G
    • 8.5.4. 27G

9. Vitreoretinal Surgery Devices Market, by Application

  • 9.1. Diabetic Retinopathy
  • 9.2. Epiretinal Membrane Surgery
  • 9.3. Macular Hole Repair
  • 9.4. Retinal Detachment Repair

10. Vitreoretinal Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital
  • 10.3. Specialty Eye Clinic

11. Vitreoretinal Surgery Devices Market, by Technology

  • 11.1. Cutting Mechanism
    • 11.1.1. Guillotine Cutter
    • 11.1.2. Ultrasonic Cutter
  • 11.2. Imaging System
    • 11.2.1. Conventional Imaging
    • 11.2.2. Three-Dimensional Imaging

12. Vitreoretinal Surgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Vitreoretinal Surgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Vitreoretinal Surgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Alcon Inc.
    • 15.3.2. Johnson & Johnson Vision Care, Inc.
    • 15.3.3. Bausch & Lomb Incorporated
    • 15.3.4. Carl Zeiss Meditec AG
    • 15.3.5. Topcon Corporation
    • 15.3.6. NIDEK Co., Ltd.
    • 15.3.7. D.O.R.C. Ophthalmic Systems b.v.
    • 15.3.8. Synergetics USA, Inc.
    • 15.3.9. IRIDEX Corporation
    • 15.3.10. Santen Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. VITREORETINAL SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. VITREORETINAL SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VITREORETINAL SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ENDOLASER PHOTOCOAGULATION PROBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ENDOLASER PHOTOCOAGULATION PROBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ENDOLASER PHOTOCOAGULATION PROBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ENDOLASER PHOTOCOAGULATION PROBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ENDOLASER PHOTOCOAGULATION PROBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ENDOLASER PHOTOCOAGULATION PROBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ILLUMINATION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ILLUMINATION SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ILLUMINATION SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ILLUMINATION SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ILLUMINATION SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ILLUMINATION SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR TAMPONADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR TAMPONADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR TAMPONADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR TAMPONADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR TAMPONADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR TAMPONADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TROCAR CANNULA SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TROCAR CANNULA SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TROCAR CANNULA SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TROCAR CANNULA SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TROCAR CANNULA SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TROCAR CANNULA SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 20G, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 20G, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 20G, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 20G, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 20G, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 20G, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 23G, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 23G, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 23G, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 23G, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 23G, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 23G, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 25G, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 25G, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 25G, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 25G, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 25G, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 25G, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 27G, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 27G, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 27G, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 27G, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 27G, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY 27G, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY MACULAR HOLE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY MACULAR HOLE REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY MACULAR HOLE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY MACULAR HOLE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY MACULAR HOLE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY MACULAR HOLE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GUILLOTINE CUTTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GUILLOTINE CUTTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GUILLOTINE CUTTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GUILLOTINE CUTTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GUILLOTINE CUTTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GUILLOTINE CUTTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC CUTTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC CUTTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC CUTTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC CUTTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC CUTTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC CUTTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY THREE-DIMENSIONAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY THREE-DIMENSIONAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY THREE-DIMENSIONAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY THREE-DIMENSIONAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY THREE-DIMENSIONAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY THREE-DIMENSIONAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC VITREORETINAL SURGERY DEVICES MARKET SIZE, BY IMAGING SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL VITREORETINAL SURGERY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN VITREORETINAL SURGERY DEVICES MARKET SIZE, BY CUTTING MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN VITREORETIN